Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Conci, Simone; Cipriani, Federica; Donadon, Matteo; Marchitelli, Ivan; Ardito, Francesco; Famularo, Simone; Perri, Pasquale; Iaria, Maurizio; Ansaloni, Luca; Zanello, Matteo; La Barba, Giuliano; Patauner, Stefan; Pinotti, Enrico; Molfino, Sarah; Germani, Paola; Romano, Maurizio; Sciannamea, Ivano; Ferrari, Cecilia; Manzoni, Alberto; Troci, Albert; Fumagalli, Luca; Delvecchio, Antonella; Floridi, Antonio; Memeo, Riccardo; Chiarelli, Marco; Crespi, Michele; Zimmitti, Giuseppe; Griseri, Guido; Antonucci, Adelmo; Zanus, Giacomo; Tarchi, Paola; Baiocchi, Gian Luca; Zago, Mauro; Frena, Antonio; Ercolani, Giorgio; Jovine, Elio; Maestri, Marcello; Valle, Raffaele Dalla; Grazi, Gian Luca; Romano, Fabrizio; Giuliante, Felice; Torzilli, Guido; Aldrighetti, Luca; Ruzzenente, Andrea;
• Is Part Of: European journal of surgical oncology. Volume 48:Issue 1(2022)
• Page Start: 103
• Page End: 112
• Publication Date: 2022-01
• Subjects: Metabolic associated fatty liver disease -- Metabolic syndrome -- NAFLD -- Hepatocellular carcinoma -- Hepatectomy -- Liver resection; Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2021.07.015
• Languages: English
• ISSNs: 0748-7983

Abstract

Abstract: Background and aims: We investigated the clinical impact of the newly defined metabolic-associated fatty liver disease (MAFLD) in patients undergoing hepatectomy for HCC (MAFLD-HCC) comparing the characteristics and outcomes of patients with MAFLD-HCC to viral- and alcoholic-related HCC (HCV-HCC, HBV-HCC, A-HCC). Methods: A retrospective analysis of patients included in the He.RC.O.Le.S. Group registry was performed. The characteristics, short- and long-term outcomes of 1315 patients included were compared according to the study group before and after an exact propensity score match (PSM). Results: Among the whole study population, 264 (20.1%) had MAFLD-HCC, 205 (15.6%) had HBV-HCC, 671 (51.0%) had HCV-HCC and 175 (13.3%) had A-HCC. MAFLD-HCC patients had higher BMI (p < 0.001), Charlson Comorbidities Index (p < 0.001), size of tumour (p < 0.001), and presence of cirrhosis (p < 0.001). After PSM, the 90-day mortality and severe morbidity rates were 5.9% and 7.1% in MAFLD-HCC, 2.3% and 7.1% in HBV-HCC, 3.5% and 11.7% in HCV-HCC, and 1.2% and 8.2% in A-HCC (p = 0.061 and p = 0.447, respectively). The 5-year OS and RFS rates were 54.4% and 37.1% in MAFLD-HCC, 64.9% and 32.2% in HBV-HCC, 53.4% and 24.7% in HCV-HCC and 62.0% and 37.8% in A-HCC (p = 0.345 and p = 0.389, respectively). Cirrhosis, multiple tumours, size and satellitosis seems to be the independent predictors of OS. Conclusion: Hepatectomy for MAFLD-HCC seems to have a higher but acceptable operative risk. However, long-term outcomes seems to be related to clinical and pathological factors rather than aetiological risk factors.